Pyrimidine-2,4-dione HIV reverse transcriptase inhibitors
US8106064B2 · kind B2 · utility
4Cited by
11References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2007 |
| Grant date | Jan 31, 2012 |
| Priority date | — |
| Expiry date | Oct 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention is related to pyrimidine-2,4-dione HIV reverse transcriptase inhibitors of Formula (I), (II), or (III):or a pharmaceutically acceptable salt, thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.